[Diabetic neuropathies (part 2): complications, comorbidities and etiology].
Haslbeck
M
M
Zentrum München-Neuherberg, München.
D000368:Aged; D000818:Animals; D001008:Anxiety Disorders / Q000453:epidemiology; D002675:Child, Preschool; D015897:Comorbidity; D003704:Dementia / Q000453:epidemiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003929:Diabetic Neuropathies / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism; D003937:Diagnosis, Differential; D004066:Digestive System Diseases / Q000453:epidemiology / Q000209:etiology*; D004195:Disease Models, Animal; D005260:Female; D005858:Germany; D006801:Humans; D002546:Ischemic Attack, Transient / Q000209:etiology; D008297:Male; D010146:Pain / Q000209:etiology*; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000453:epidemiology; D012307:Risk Factors; D012891:Sleep Apnea Syndromes / Q000209:etiology / Q000628:therapy; D012893:Sleep Wake Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D020521:Stroke / Q000209:etiology*